A patient-derived xenograft (PDX) platform to optimize omics-driven precision medicine in bladder cancer.
Chong-xian Pan
Research Funding - Abbott Laboratories; Novartis
Hongyong Zhang
No relevant relationships to disclose
Clifford Tepper
No relevant relationships to disclose
Paramita Ghosh
No relevant relationships to disclose
Sheri Kuslak-Meyer
No relevant relationships to disclose
Susan D. Airhart
No relevant relationships to disclose
David R. Gandara
No relevant relationships to disclose
Edison T. Liu
No relevant relationships to disclose
Ralph deVere White
No relevant relationships to disclose